Wanwisa Dejnirattisai

Best Publications

• SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

  Unknown

  1679
  Citations

• Broad and strong memory CD4 + and CD8 + T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19.

  Y Peng;A J Mentzer;G Liu;G Liu;X Yao

  1277
  Citations

• Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans

  Wanwisa Dejnirattisai;Amonrat Jumnainsong;Naruthai Onsirisakul;Naruthai Onsirisakul;Patricia Fitton

  1111
  Citations

• Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.

  D Zhou;W Dejnirattisai;P Supasa;C Liu

  1044
  Citations

• Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus

  Wanwisa Dejnirattisai;Piyada Supasa;Piyada Supasa;Wiyada Wongwiwat;Alexander Rouvinski

  1027
  Citations

• Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.

  Juthathip Mongkolsapaya;Wanwisa Dejnirattisai;Xiao-ning Xu;Sirijitt Vasanawathana

  1021
  Citations

• Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study

  Unknown

  730
  Citations

• Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.

  C Liu;H M Ginn;W Dejnirattisai;P Supasa

  686
  Citations

• Structural basis of potent Zika–dengue virus antibody cross-neutralization

  Giovanna Barba-Spaeth;Wanwisa Dejnirattisai;Alexander Rouvinski;Marie Christine Vaney

  572
  Citations

• A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus

  Wanwisa Dejnirattisai;Wiyada Wongwiwat;Sunpetchuda Supasa;Sunpetchuda Supasa;Xiaokang Zhang;Xiaokang Zhang

  550
  Citations

• Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines

  Unknown

  401
  Citations

• The antigenic anatomy of SARS-CoV-2 receptor binding domain.

  Wanwisa Dejnirattisai;Daming Zhou;Helen M. Ginn;Helen M.E. Duyvesteyn

  396
  Citations

• Recognition determinants of broadly neutralizing human antibodies against dengue viruses

  Alexander Rouvinski;Alexander Rouvinski;Pablo Guardado-Calvo;Pablo Guardado-Calvo;Giovanna Barba-Spaeth;Giovanna Barba-Spaeth;Stéphane Duquerroy;Stéphane Duquerroy;Stéphane Duquerroy

  395
  Citations

• Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

  Unknown

  369
  Citations

• T Cell Responses in Dengue Hemorrhagic Fever: Are Cross-Reactive T Cells Suboptimal?

  Juthathip Mongkolsapaya;Thaneeya Duangchinda;Wanwisa Dejnirattisai;Sirijit Vasanawathana

  325
  Citations

• Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.

  R P Payne;S Longet;J A Austin;D T Skelly

  321
  Citations

• Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom.

  J Wei;N Stoesser;P Matthews;P Matthews;D Ayoubkhani

  319
  Citations

• Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum

  Unknown

  318
  Citations

• Immunodominant T-cell responses to dengue virus NS3 are associated with DHF

  Thaneeya Duangchinda;Wanwisa Dejnirattisai;Sirijit Vasanawathana;Wannee Limpitikul

  299
  Citations

• Potent cross-reactive antibodies following Omicron breakthrough in vaccinees

  Unknown

  277
  Citations